Thus, the knockdown of Smad4 produced identical phenotypes in the HCC cells as the knockdown of TβRII suggesting that the Smad pathway mediates both the growth inhibitory and cell survival activity of TGF-β signaling in the HCC cells. Here, SMAD4 is linked to hepatocellular carcinoma.